pimobendan vetmedica 1,25 mg comprime a croquer pour chiens
boehringer ingelheim vetmedica gmbh - pimobendan 1.25 mg - chewable tablet - dogs - pimobendane
pimobendan vetmedin 1.25 mg chewable tablets for dogs
boehringer ingelheim vetmedica gmbh - pimobendan 1.25 mg - chewable tablet - dogs - pimobendane
pimobendan vetmedica 2,5 mg comprime a croquer pour chiens
boehringer ingelheim vetmedica gmbh - pimobendan 2.5 mg - chewable tablet - dogs - pimobendane
pimobendan vetmedin 2.5 mg chewable tablets for dogs
boehringer ingelheim vetmedica gmbh - pimobendan 2.5 mg - chewable tablet - dogs - pimobendane
fatrobendan 1.25 mg, chewable tablets for dogs
fatro s.p.a. - pimobendan - chewable tablet - 1.25 milligram(s) - pimobendan
fatrobendan 10 mg, chewable tablets for dogs
fatro s.p.a. - pimobendan - chewable tablet - 10 milligram(s) - pimobendan
fatrobendan 5 mg, chewable tablets for dogs
fatro s.p.a. - pimobendan - chewable tablet - 5 milligram(s) - pimobendan
vetmedin-ca1- pimobendan tablet, chewable
boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - vetmedin-ca1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with stage b2 preclinical myxomatous mitral valve disease (2019 acvim consensus statement1 ). stage b2 preclinical myxomatous mitral valve disease (mmvd) refers to dogs with asymptomatic mmvd that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly. do not administer vetmedin-ca1 in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. do not administer vetmedin-ca1 to dogs with stage a or b1 preclinical mmvd (2019 acvim consensus statement) due to the risk of cardiac pathology associated with exaggerated hemodynamic responses to vetmedin-ca1.
cormedin 1.25 mg tablets for dogs
jurox pty limited - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 1.25 mg/ta - cardiovascular system
pimobendan
eurovet animal health bv - pimobendan - unknown - pimobendan pyridazinone active 0.0 - active constituent